Literature DB >> 12384238

Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.

Md Haronur Rashid1, Hiroshi Ueda.   

Abstract

The effect of the nicotinic acetylcholine receptor (nAChR) agonists at the spinal level has not been well studied in neuropathic states. In the present report, we demonstrate the efficacy of intrathecal nicotinic agonists in partial sciatic nerve injury-induced neuropathy model mice. Intrathecal (i.t.) administration of (-)nicotine and (+)epibatidine, at doses without undesirable effects, had no antinociceptive action in sham-operated mice. However, they completely reversed the thermal and mechanical hyperalgesia in partial sciatic nerve-injured mice. This neuropathy-specific analgesic action of i.t. (-)nicotine and (+)epibatidine is attributed to different subtypes of nAChRs at the spinal level. After antagonism experiments with mecamylamine, dihydro-beta-erythroidine and methyllycaconitine, it was observed that (-)nicotine-induced analgesia was mediated through the alpha4beta2 subtype of nAChR while the (+)epibatidine-induced one was mediated through non-alpha4beta2 subtype of nAChR. Moreover, i.t. pretreatment with NMDA receptor antagonist did not block nicotinic analgesia. Similar to nicotinic agonists, gamma-aminobutyric acid receptor (GABA(A)) agonist muscimol (i.t.) produced neuropathy-specific analgesic action giving analgesia only in nerve-injured mice. The GABA(A) antagonists bicuculline and picrotoxin significantly blocked the analgesic effects of muscimol as well as that of (-)nicotine and (+)epibatidine. On the other hand, i.t. injection of nicotinic antagonist mecamylamine and GABA(A) antagonist picrotoxin in sham-operated mice induced a thermal hyperalgesia without any effects in nerve-injured animals suggesting the presence of a tonic inhibitory tone on nociceptive transmission through the spinal cholinergic-GABAergic system. These results also suggest that the neuropathy-specific analgesic action of intrathecal nicotinic agonists was due to stimulation of this cholinergic-GABAergic system whose inhibitory tone had been reduced due to injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384238     DOI: 10.1016/s0006-8993(02)03270-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  19 in total

1.  Ondansetron reverses antihypersensitivity from clonidine in rats after peripheral nerve injury: role of γ-aminobutyric acid in α2-adrenoceptor and 5-HT3 serotonin receptor analgesia.

Authors:  Ken-ichiro Hayashida; Masafumi Kimura; Masaru Yoshizumi; Shotaro Hobo; Hideaki Obata; James C Eisenach
Journal:  Anesthesiology       Date:  2012-08       Impact factor: 7.892

2.  Intrathecal injection of an alpha seven nicotinic acetylcholine receptor agonist attenuates gp120-induced mechanical allodynia and spinal pro-inflammatory cytokine profiles in rats.

Authors:  Lisa C Loram; Jacqueline A Harrison; Lindsey Chao; Frederick R Taylor; Anireddy Reddy; Carissa L Travis; Rona Giffard; Yousef Al-Abed; Kevin Tracey; Steven F Maier; Linda R Watkins
Journal:  Brain Behav Immun       Date:  2010-03-28       Impact factor: 7.217

3.  Epidural administration of neostigmine-loaded nanofibers provides extended analgesia in rats.

Authors:  Masoomeh Yosefifard; Majid Hassanpour-Ezatti
Journal:  Daru       Date:  2014-11-18       Impact factor: 3.117

4.  Alleviation of chronic pain following rat spinal cord compression injury with multimodal actions of huperzine A.

Authors:  Dou Yu; Devang K Thakor; Inbo Han; Alexander E Ropper; Hariprakash Haragopal; Richard L Sidman; Ross Zafonte; Steven C Schachter; Yang D Teng
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-05       Impact factor: 11.205

5.  Peripheral nerve injury alters spinal nicotinic acetylcholine receptor pharmacology.

Authors:  Tracey Young; Shannon Wittenauer; Renee Parker; Michelle Vincler
Journal:  Eur J Pharmacol       Date:  2008-06-11       Impact factor: 4.432

6.  High affinity binding of epibatidine to serotonin type 3 receptors.

Authors:  Renaldo C Drisdel; Douglas Sharp; Tricia Henderson; Tim G Hales; William N Green
Journal:  J Biol Chem       Date:  2007-08-15       Impact factor: 5.157

7.  Spinal alpha3beta2* nicotinic acetylcholine receptors tonically inhibit the transmission of nociceptive mechanical stimuli.

Authors:  Tracey Young; Shannon Wittenauer; J Michael McIntosh; Michelle Vincler
Journal:  Brain Res       Date:  2008-07-02       Impact factor: 3.252

8.  Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters.

Authors:  Corinne G Jolivalt; Corinne A Lee; Khara M Ramos; Nigel A Calcutt
Journal:  Pain       Date:  2008-08-27       Impact factor: 6.961

Review 9.  Neuronal nicotinic receptors as analgesic targets: it's a winding road.

Authors:  Iboro C Umana; Claire A Daniele; Daniel S McGehee
Journal:  Biochem Pharmacol       Date:  2013-08-12       Impact factor: 5.858

10.  Systemic administration of an alpha-7 nicotinic acetylcholine agonist reverses neuropathic pain in male Sprague Dawley rats.

Authors:  Lisa C Loram; Frederick R Taylor; Keith A Strand; Steven F Maier; Jason D Speake; Kristen G Jordan; John W James; Steven P Wene; Robert C Pritchard; Heather Green; Katherine Van Dyke; Anatoly Mazarov; Sharon R Letchworth; Linda R Watkins
Journal:  J Pain       Date:  2012-12       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.